BioSpace News Archive

Drug Development

Polynoma Presenting Final Analysis of MAVIS Phase III Part B1 Data of Its Investigational Melanoma Vaccine, Seviprotimut-L, at ASCO20 Virtual Scientific Program

Study data show a durable recurrence-free survival clinical benefit in patients with localized melanoma, supporting the potential use of seviprotimut-L as an adjuvant treatment

May 13, 2020
·
11 min read
Drug Development

MEI Pharma and Kyowa Kirin Announce Updated Clinical Data from the Phase 1b Study Evaluating ME-401 on an Intermittent Schedule in Patients with Follicular Lymphoma and Other B-cell Malignancies;

Data to be Featured in the American Society of Clinical Oncology 2020 Virtual Scientific Program

May 13, 2020
·
10 min read
Biotech Beach

Amgen Showcases Oncology Pipeline At ASCO 2020

Updated Data Evaluating Sotorasib (AMG 510), a First-in-Class Investigational KRASG12C Inhibitor, in Colorectal Cancer and Other Solid Tumors

May 13, 2020
·
26 min read
Business

Liminal Biosciences Reports Q1 2020 Results

Liminal BioSciences Inc., a clinical-stage biopharmaceutical company reported its financial results for the first quarter ended March 31, 2020.

May 13, 2020
·
8 min read
Genetown

Sanofi to showcase oncology portfolio and innovative pipeline at ASCO20 Virtual Scientific Program

New data for Sarclisa® (isatuximab-irfc) and Jevtana® (cabazitaxel) in difficult-to-treat cancers reinforce breadth and depth of portfolio

May 13, 2020
·
30 min read
Pharm Country

Regeneron Presentations at ASCO 2020 Showcase Diverse Clinical Oncology Portfolio

Regeneron Pharmaceuticals, Inc. announced the company will share updates from its diverse clinical oncology portfolio at the 2020 American Society of Clinical Oncology Annual Meeting from May 29-31 taking place virtually.

May 13, 2020
·
18 min read
Deals

Akumin Provides Business Update - May 13, 2020

Akumin Inc. announced its financial results and management’s discussion and analysis for the quarter-ended March 31, 2020 would be available on or before June 5, 2020 due to logistics and delays caused by the COVID-19 pandemic.

May 13, 2020
·
6 min read
BioMidwest

Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at ASCO 2020 Annual Meeting

Marker Therapeutics, Inc. announced that updated clinical data from an investigator-sponsored Phase 1/2 trial led by Baylor College of Medicine were selected for presentation during a poster session at the upcoming American Society of Clinical Oncology Annual Meeting.

May 13, 2020
·
3 min read
Drug Development

Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patients with High/Very-high Risk Myelodysplastic Syndromes

Data to be Featured in the American Society of Clinical Oncology Annual 2020 Virtual Scientific Program on May 29, 2020 at 8:00 a.m. EDT

May 13, 2020
·
8 min read
Pharm Country

Daiichi Sankyo to Present New Research Data Across DXd ADC Portfolio at 2020 ASCO Annual Meeting

Daiichi Sankyo Company, Limited announced that it will present new research data across its DXd antibody drug conjugate portfolio at the 2020 American Society of Clinical Oncology Virtual Scientific Program to be held May 29 to May 31.

May 13, 2020
·
25 min read